January 28, 2025

Carbonated Water Found to Lower Blood Glucose

Consumption leads to "a significant decrease in blood glucose levels as blood passes through the dialyzer."

Conexiant

January 24, 2025

A1C Benefits Tied to H. pylori Treatment

Researchers evaluated the safety, efficacy, and glycemic benefits of vonoprazan-amoxicillin dual therapy for H. pylori eradication in type 2 diabetes patients.

Conexiant

January 24, 2025

VA Study Maps GLP-1 Effects Across Systems

Large-scale study of 1.9M veterans identifies previously unreported benefits and risks of GLP-1 receptor agonists across 175 health outcomes, including reduced substance use disorders and increased pancreatitis risk.

Conexiant

January 24, 2025

AGA Updates HBV Reactivation Prophylaxis Guidelines

New evidence-based recommendations stratify antiviral prophylaxis across immunotherapies, with clear risk-based protocols for patient management.

Conexiant

January 21, 2025

Urinary Prostaglandins vs Calprotectin in IBD

Explore the latest study comparing urinary prostaglandin metabolites to fecal calprotectin for monitoring Crohn’s disease and ulcerative colitis activity.

Conexiant

January 15, 2025

IL-23p19 Inhibitor Shows 2-Year Crohn's Efficacy

"The FDA approval of Omvoh may help adults with Crohn's disease achieve long-term remission and visible healing of the intestinal lining, even if they have tried other medications that did not work or stopped working."

Conexiant

January 14, 2025

Low-Carb Diet Improves Reflux and GI Health in Obesity Study

Low-carb, high-fat diets reduced reflux symptoms and altered short-chain fatty acids in obesity.

Conexiant

January 14, 2025

Tacrolimus Versus Infliximab: Remission and Colectomy in UC

Comparative outcomes of tacrolimus and infliximab for remission induction and colectomy rates in refractory UC.

Conexiant

January 14, 2025

Allergic Multimorbidity Linked to Mucosal Healing in UC

Patients with 3+ allergic conditions had 8x higher odds of achieving mucosal healing, highlighting potential shared immune pathways.

Conexiant